🧠 A Copper-Based Compound May Help the Brain Clear Alzheimer’s Proteins — by Repairing Its “Waste Pumps”

Most Alzheimer’s drug research has focused on attacking amyloid plaques directly. A new study from Monash University suggests a different route: what if the brain’s waste-clearance system could be repaired instead?

The compound is called Cu(ATSM) — a copper-delivering molecule already studied in human safety trials for Parkinson’s disease and ALS. In a mouse model of Alzheimer’s, researchers found that Cu(ATSM) restored levels of P-glycoprotein, or P-gp — a transporter at the blood-brain barrier that helps move amyloid-beta out of the brain.

Think of P-gp as part of the brain’s drainage system. When these pumps weaken, toxic proteins can accumulate. When the researchers boosted them with Cu(ATSM), the results were striking:

• 42% reduction in toxic amyloid-beta over 56 days
• nearly 44% improvement in spatial learning
• 24.1% increase in P-gp clearance pumps at the blood-brain barrier
• evidence that repairing the blood-brain barrier may help lower amyloid burden and improve cognition

The important caveat: this was not a human Alzheimer’s trial. The results come from APP/PS1 mice — a widely used model of the disease — so the next question is whether the same mechanism works in people.

Still, the idea is powerful. Instead of only trying to destroy plaques after they form, future therapies might also help the brain restore its own clearance infrastructure.

If Alzheimer’s is partly a “drainage failure,” could repairing the brain’s plumbing become one of the next big strategies in neurodegeneration?

📄 Source: https://doi.org/10.1021/acschemneuro.6c00252

#Alzheimers #Neuroscience #DrugDiscovery #BloodBrainBarrier #CopperTherapy #science